AKTX
NASD Akari Therapeutics Plc Sponsored ADR$9.57 ↑ +1.39 (+16.99%) Trading Up from the previous close of $8.18
- YTD change
- -17.22%
- vs 20-day SMA
- +6.99%
- vs 200-day SMA
- +4.04%
Price ranges
Price & Performance
+2.24 (+37.71%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 99.9% away from all-time highs of $17,759.80
- AKTX is down 17% since the beginning of the year
- AKTX is down 70% over the past 12 months
- AKTX is up 4% over the past 1 month
- 1% of all AKTX investors are betting against AKTX
AKTX reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +962.3%.
- Previous minute
- +$0.07
- Last hour
- +$1.11
- Last 5 days
- +9.12%
- vs 8-day SMA
- +15.53%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
